Skip to main content
Clinical Trials/NCT04387279
NCT04387279
Unknown
N/A

The Effect of Patient's Perceptions for COVID-19 on the Inflammatory Bowel Disease-related Healthcare Utilization in the Hyperepidemic Area

Keimyung University Dongsan Medical Center1 site in 1 country800 target enrollmentApril 24, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
COVID-19
Sponsor
Keimyung University Dongsan Medical Center
Enrollment
800
Locations
1
Primary Endpoint
Patient's perception of COVID-19 and medical use patterns
Last Updated
5 years ago

Overview

Brief Summary

The rapid spread of COVID-19 is expected to have a significant impact on medicine as well as all sectors worldwide. In particular, inflammatory bowel disease (IBD) is a chronic immune disease in which remission and activation are repeated and must be treated consistently throughout life. In addition, patients with IBD may be vulnerable to various infectious diseases due to the immuno-compromised state due to the use of immuno-suppressants or biological agents. During a pandemic, patients with IBD may postpone hospital visits due to concerns about infection with COVID-19, and if they cannot continue drug treatment, there is a concern about the flare up IBD disease activity. Therefore, in this study, we would like to investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital ultilization.

Detailed Description

Background: In the epidemic area of COVID-19, emergency treatment of chronic diseases other than COVID-19 can be limited. Therefore, it is important to reduce the risk of exposure to COVID-19 in patients with chronic immune diseases such as IBD, but it is most important to manage well so that the underlying diseases are not exacerbated at times when emergency medical treatment may be difficult. However, there is a lack of evidence on the management policy of chronic immune diseases in the current epidemic, and only expert opinions are being presented. Aim: To investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital utilization. Material and method: This study is a multicenter, prospective, cross-sectional survey which will be consulted in Keimyung University Dongsan Medical Center and Yeungnam University Hospital. Patients with IBD aged above 18 will enrolled and surveyed about their perception about COVID-19 and status of hospital utilization during pandemic period. Patients' demographics and disease-related variables will be evaluated to identify clinical significances.

Registry
clinicaltrials.gov
Start Date
April 24, 2020
End Date
March 30, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

YooJin Lee

Professor

Keimyung University Dongsan Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patients with inflammatory growth disease, those who agreed to participate in this study

Exclusion Criteria

  • Those who are unable to understand or answer the questionnaire
  • Those who declined to participate in this study

Outcomes

Primary Outcomes

Patient's perception of COVID-19 and medical use patterns

Time Frame: 1day

Correlation between patient's perception of COVID-19 and medical use patterns during the pandemic period

Secondary Outcomes

  • Exacerbation of symptoms(1day)

Study Sites (1)

Loading locations...

Similar Trials